US Stock MarketDetailed Quotes
SRTS Sensus Healthcare
- 8.600
- -0.010-0.12%
Close Nov 27 16:00 ET
- 8.600
- 0.0000.00%
Post 20:01 ET
140.95MMarket Cap15.09P/E (TTM)
8.830High8.310Low194.07KVolume8.610Open8.610Pre Close1.65MTurnover1.50%Turnover Ratio286.67P/E (Static)16.39MShares9.32952wk High2.60P/B111.20MFloat Cap2.05052wk Low--Dividend TTM12.93MShs Float15.250Historical High--Div YieldTTM6.04%Amplitude1.760Historical Low8.510Avg Price1Lot Size
Sensus Healthcare Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 794.34%3.95M | 470.08%4.23M | -36.52%-8.19M | -51.91%-2.15M | 126.38%2.67M | -88.13%442K | -60.86%742K | -294.58%-6M | -393.71%-1.41M | -468.15%-10.11M |
| Net income from continuing operations | 183.74%1.22M | 524.21%1.61M | 220.06%2.27M | -98.00%485K | 48.82%4.21M | -179.33%-1.45M | -110.78%-380K | -111.79%-1.89M | 488.59%24.24M | -46.80%2.83M |
| Operating gains losses | ---- | ---- | ---- | 99.67%-42K | --0 | ---- | ---- | ---- | -26,870.21%-12.58M | 19,600.00%197K |
| Depreciation and amortization | -3.77%102K | -39.06%78K | -2.48%118K | -9.43%461K | -12.40%106K | -52.25%106K | 72.97%128K | 31.52%121K | -16.97%509K | -14.18%121K |
| Deferred tax | -342.40%-553K | 33.93%-331K | 203.12%827K | 75.07%-427K | 1,001.80%1M | -105.84%-125K | ---501K | 78.58%-802K | ---1.71M | ---111K |
| Change In working capital | 72.08%3.17M | 108.88%2.73M | -212.42%-11.65M | 72.45%-3.56M | 78.43%-2.98M | 363.75%1.84M | 171.33%1.31M | -209.04%-3.73M | -110.56%-12.92M | -79.96%-13.81M |
| -Change in receivables | -44.74%1.25M | -63.96%1.29M | -296.67%-8.98M | 225.08%6.65M | 62.56%-3.76M | -22.33%2.26M | 1,462.88%3.58M | 187.17%4.57M | 36.98%-5.31M | -23.45%-10.05M |
| -Change in inventory | 105.10%162K | 148.67%1.84M | -0.35%-2.87M | -168.79%-8.58M | 207.45%1.24M | -347.67%-3.17M | -690.19%-3.79M | -45.00%-2.86M | -216.67%-3.19M | -509.57%-1.16M |
| -Change in prepaid assets | -41.33%1.61M | -88.51%338K | 79.67%-685K | 168.60%3.28M | 131.17%960K | 383.10%2.74M | 220.14%2.94M | -1,911.83%-3.37M | -757.09%-4.77M | -279.78%-3.08M |
| -Change in payables and accrued expense | 1,087.93%689K | 53.80%-456K | 161.36%910K | -312.02%-3.58M | -190.27%-1.17M | 101.76%58K | -188.60%-987K | -136.84%-1.48M | 75.57%1.69M | -0.77%1.3M |
| -Change in other current assets | -533.67%-425K | 134.66%96K | 47.45%-165K | -283.67%-540K | 49.46%-47K | -74.68%98K | ---277K | ---314K | --294K | ---93K |
| -Change in other current liabilities | 2.08%-47K | 20.69%-46K | 15.22%-39K | -1.01%-201K | -8.89%-49K | 68.83%-48K | ---58K | ---46K | ---199K | ---45K |
| -Change in other working capital | 28.71%-72K | -228.16%-338K | 178.32%177K | 59.20%-583K | 77.76%-153K | 75.66%-101K | -217.05%-103K | 45.41%-226K | -68.91%-1.43M | -119.81%-688K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 794.34%3.95M | 470.08%4.23M | -36.52%-8.19M | -51.91%-2.15M | 126.38%2.67M | -88.13%442K | -60.86%742K | -294.58%-6M | -393.71%-1.41M | -468.15%-10.11M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -1,187.10%-337K | 89.66%-3K | -23.28%-233K | -101.26%-187K | 0 | 151.67%31K | 35.56%-29K | -101.26%-189K | 11,404.65%14.84M | 73.68%-10K |
| Net PPE purchase and sale | -2,963.64%-337K | 89.66%-3K | -23.28%-233K | -44.03%-229K | --0 | 81.67%-11K | 35.56%-29K | -329.55%-189K | -24.22%-159K | 73.68%-10K |
| Net other investing changes | ---- | ---- | ---- | -99.72%42K | --0 | ---- | ---- | ---- | 5,736.58%15M | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -1,187.10%-337K | 89.66%-3K | -23.28%-233K | -101.26%-187K | --0 | 151.67%31K | 35.56%-29K | -101.26%-189K | 11,404.65%14.84M | 73.68%-10K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 23.08%-30K | 17K | 0 | 98.35%-40K | 99.64%-7K | -118.48%-39K | 0 | -97.80%6K | -951.08%-2.43M | -3,481.48%-1.93M |
| Net issuance payments of debt | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 76.39%-51K | --0 |
| Net common stock issuance | ---- | ---- | ---- | 99.10%-27K | --0 | ---- | ---- | ---- | ---3M | ---1.99M |
| Proceeds from stock option exercised by employees | --17K | --17K | --0 | -93.71%46K | --0 | --0 | --0 | -86.74%46K | --731K | --60K |
| Net other financing activities | ---- | ---- | ---- | 45.87%-59K | ---7K | 86.05%-12K | --0 | -73.91%-40K | -626.67%-109K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 23.08%-30K | --17K | --0 | 98.35%-40K | 99.64%-7K | -118.48%-39K | --0 | -97.80%6K | -951.08%-2.43M | -3,481.48%-1.93M |
| Net cash flow | ||||||||||
| Beginning cash position | -5.39%18.97M | -23.85%14.73M | -9.29%23.15M | 75.77%25.52M | -45.48%20.49M | -40.50%20.05M | -41.09%19.34M | 75.77%25.52M | -2.60%14.52M | 129.25%37.58M |
| Current changes in cash | 726.27%3.59M | 495.23%4.24M | -36.25%-8.42M | -121.56%-2.37M | 122.07%2.66M | -88.80%434K | -18.33%713K | -133.75%-6.18M | 2,935.31%11M | -544.07%-12.06M |
| End cash Position | 10.11%22.56M | -5.39%18.97M | -23.85%14.73M | -9.29%23.15M | -9.29%23.15M | -45.48%20.49M | -40.50%20.05M | -41.09%19.34M | 75.77%25.52M | 75.77%25.52M |
| Free cash flow | 738.98%3.62M | 492.85%4.23M | -36.11%-8.42M | -51.11%-2.37M | 126.36%2.67M | -88.23%431K | -61.48%713K | -303.62%-6.19M | -279.47%-1.57M | -456.82%-10.12M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data